Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. starting in 2027, to cut costs for insured patients

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. starting in 2027, to cut costs for insured patients

https://www.cnbc.com/2026/02/24/novo-nordisk-to-slash-wegovy-ozempic-us-list-prices-by-up-to-50percent.html

Posted by ControlCAD